| Mar 2, 2023 |
Mar 6, 2023 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
41.3
|
-6,871
|
-3.64%
|
✓
|
$24.9K |
| Feb 8, 2023 |
Feb 10, 2023 |
C4 Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+5,667
|
100.00%
|
✗
|
$31.7K |
| Feb 7, 2023 |
Feb 9, 2023 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-2,485
|
-1.30%
|
✓
|
$13.6K |
| Nov 16, 2022 |
Nov 18, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
41.3
|
-6,255
|
-3.17%
|
✓
|
$28.1K |
| Aug 16, 2022 |
Aug 18, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-5,940
|
-2.92%
|
✓
|
$29.9K |
| Jun 8, 2022 |
Jun 10, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-5,853
|
-2.80%
|
✓
|
$33K |
| May 17, 2022 |
May 19, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-5,582
|
-2.62%
|
✓
|
$29.7K |
| Mar 1, 2022 |
Mar 3, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
91.3
|
+57,472
|
36.91%
|
✓
|
$37.1K |
| Feb 7, 2022 |
Feb 9, 2022 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-2,496
|
-1.58%
|
✓
|
$36.1K |
| Nov 16, 2021 |
Nov 18, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
41.3
|
-3,655
|
-2.26%
|
✓
|
$62.6K |
| Aug 17, 2021 |
Aug 19, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-3,579
|
-2.17%
|
✓
|
$44.9K |
| Jun 8, 2021 |
Jun 9, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
37.5
|
-5,820
|
-3.41%
|
✓
|
$81.8K |
| May 18, 2021 |
May 20, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
41.3
|
-3,616
|
-2.10%
|
✓
|
$52.6K |
| Mar 26, 2021 |
Mar 30, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,761
|
-1.01%
|
✓
|
$25.7K |
| Mar 2, 2021 |
Mar 4, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
51.3
|
-1,461
|
-0.83%
|
✓
|
$24.5K |
| Feb 8, 2021 |
Feb 9, 2021 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,759
|
-1.33%
|
✓
|
$35.9K |
| Nov 17, 2020 |
Nov 18, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,469
|
-1.10%
|
✓
|
$29K |
| Aug 18, 2020 |
Aug 20, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,496
|
-1.11%
|
✓
|
$18.1K |
| Jun 9, 2020 |
Jun 10, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-3,924
|
-2.82%
|
✓
|
$39.9K |
| May 18, 2020 |
May 20, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,428
|
-1.03%
|
✓
|
$16K |
| Mar 27, 2020 |
Mar 30, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
48.8
|
-1,827
|
-1.31%
|
✓
|
$16.8K |
| Feb 6, 2020 |
Feb 10, 2020 |
Atara Biotherapeutics, Inc.
|
CFO |
Sell |
45.0
|
-1,781
|
-2.40%
|
✓
|
$25.3K |
| Jul 27, 2018 |
Sep 11, 2018 |
Atara Biotherapeutics, Inc.
|
CFO |
Buy |
87.5
|
+2,000
|
4.44%
|
✗
|
$73.6K |